Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.
from NYT > Health https://ift.tt/2K2PlFf
via health&fitness
Aucun commentaire:
Enregistrer un commentaire